Patanol Eye Drops 0.1% (Olopatadine Hydrochloride)
Olopatadine Hydrochloride 1.11mg
Eye drops · Prescription medication
Korea Hutex Pharmaceutical Co., Ltd.
MFDS item code 201804712 · Approved 2018.11.28 · Insurance code 649104182
Relief of symptoms of allergic conjunctivitis
Helps alleviate itching and swelling of the eyes caused by allergic conjunctivitis, and reduces inflammation. This medication improves discomfort in the eyes by inhibiting allergic reactions. It is used to effectively treat patients' symptoms.
Instill 1 drop twice a day (every 6 to 8 hours). Treatment may continue for a maximum of 4 months if needed.
This medication should not be used in patients with allergic reactions to the active ingredient or any of the formulation components. Rarely, neurological side effects such as headaches, altered taste, or dizziness may occur. Eye-related side effects may include punctate keratitis, keratitis, eye pain, dry eyes, swelling around the eyes, itching of the eyes, eye discharge, conjunctival injection, changes in eyelid skin, and discomfort in the eyes. Dryness of the nose or symptoms of rhinitis may occur, and skin reactions such as dry mouth or dermatitis have been reported rarely. Fatigue may also be experienced intermittently. After using this medication, the eyes may become excessively sensitive, and symptoms such as weakness, cold symptoms, nausea, pharyngitis, sinusitis, skin rashes, abdominal pain, liver function abnormalities, elevated blood pressure, abnormal blood tests, and urinary difficulties may occasionally manifest. This medication contains phosphates, which can rarely cause corneal calcification in patients with severe corneal damage, so caution is advised. This medication is a non-sedating antihistamine and may cause temporary blurriness of vision after use, so caution should be exercised when driving or operating machinery. You should wait until your vision is clear again. Patients receiving long-term steroid therapy should reduce their steroid dosage gradually under medical supervision while using this medication. For seasonal allergy patients, it is advisable to start this medication before symptoms worsen and to continue using it until symptoms resolve. If ineffective, it is advisable not to use it long-term, and the benzalkonium chloride contained in this medication may cause eye irritation and discolor contact lenses, so caution is necessary when wearing contact lenses. Contact lenses should be worn at least 15 minutes after instillation, and if there is conjunctival injection, wearing contact lenses should be avoided. This medication is for local ophthalmic use only, and the tip of the container should be kept clean and tightly closed after use. When using with other eye drops, a minimum interval of 5 minutes should be maintained, and ointments should be administered last. Pregnant or breastfeeding women should consult a physician before using this medication, especially during breastfeeding where careful consideration of potential effects on the baby should be taken. Children under 3 years of age should be used with caution since the safety and efficacy of this medication have not been established. No special dosage adjustments are necessary for the elderly. In case of overdose, patients should be closely monitored and receive appropriate management. This medication should be stored out of direct sunlight and in a cool place, away from children's reach. Additionally, the use of this medication may affect allergy testing, so it is advisable not to use it prior to testing.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a container that blocks light, at room temperature between 4 and 25 degrees Celsius. This storage method helps maintain the medication's effectiveness over time.
A clear to slightly yellowish liquid in an opaque white plastic container for ophthalmic use
6 milliliters/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Olopatadine Hydrochloride 1.11mg
Eye drops · Prescription medication
Korea Hutex Pharmaceutical Co., Ltd.
Olopatadine Hydrochloride 1.11mg
Eye drops · Prescription medication
Novartis Korea Co., Ltd.
Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
Korea Kyowa Kirin Co., Ltd.
Olopatadine Hydrochloride 2.22mg
Eye drops · Prescription medication
Novartis Korea Co., Ltd.

Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
International Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.